The ROE as of September 2024 (TTM) for InVitro International (IVRO) is 8.70%

According to InVitro International’s latest financial reports and current stock price. The company's current ROE is 8.70%. This represents a change of 298.30% compared to the average of 2.19% of the last 4 quarters.

InVitro International (IVRO) Historical ROE (quarterly & annually)

How has IVRO ROE performed in the past?

The mean historical ROE of InVitro International over the last ten years is 6.51%. The current 8.70% ROE has changed 33.67% with respect to the historical average. Over the past ten years (40 quarters), IVRO's ROE was at its highest in in the June 2021 quarter at 6.12%. The ROE was at its lowest in in the March 1993 quarter at -200.00%.

InVitro International (IVRO) ROE by Quarter and Year

Discovering the peaks and valleys of InVitro International ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InVitro International (IVRO) Average ROE

How has IVRO ROE performed in the past?

The current ROE of InVitro International (IVRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

InVitro International (IVRO) ROE vs. Peers

How is IVRO’s ROE compared to its peers?

InVitro International’s ROE is less than Izotropic Corporation (42.64%), greater than Biodesix, Inc. (-525.32%), greater than Neuronetics, Inc. (-109.00%), greater than Star Equity Holdings, Inc. (-11.03%), greater than Burning Rock Biotech Limited (-74.92%), greater than DarioHealth Corp. (-7.91%), greater than Genetron Holdings Limited (-36.51%), greater than Sera Prognostics, Inc. (-46.71%), greater than Olink Holding AB (publ) (-7.07%), greater than Exagen Inc. (-78.90%), less than VolitionRx Limited (274.42%), greater than Intelligent Bio Solutions Inc. (-166.51%), greater than bioAffinity Technologies, Inc. (-170.13%), greater than SeqLL Inc. (-0.04%), greater than HTG Molecular Diagnostics, Inc. (-604.85%), less than T2 Biosystems, Inc. (213.51%), greater than Biocept, Inc. (-761.50%), greater than iSpecimen Inc. (-115.37%),

Build a custom stock screener for InVitro International (IVRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVitro International using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVitro International (IVRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVitro International or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.